Earnings History Data for Gemini Therapeutics, Inc. (GMTX) - NYSE NASDAQ

To lookup another company type a stock symbol and press 'Go'. The overview will show the earnings release info that is available in TheStockCatalyst database for the company.

For historic stock the Extended Hours price data shown are from just before market open on the day of release for premarket earnings releases and of the day after release for afterhours earnings releases. The normal price data is from just before market close on the days of release for premarket releases and the day after release for afterhours releases.

See the full list of available companies here.

Gemini Therapeutics, Inc.

Gemini Therapeutics Inc. is a clinical stage precision medicine company. It engages in developing novel therapeutic compounds to treat genetically defined age-related macular degeneration. The company's lead candidate principally includes GEM103. Its pipeline includes recombinant proteins, gene therapies and monoclonal antibodies. Gemini Therapeutics Inc., formerly known as FS Development Corp., is based in CAMBRIDGE, Mass.
Release Date Time Est. Time Symbol Name Market Cap (M) Rep. EPS Est. EPS Last years EPS SeekingAlpha Headline Price Change Ext. Hours Price Ext. Hours Change 52 Week Range Volume Avg. Volume Ext. Hours Volume Top Mover
10-03-2022 PM 7:00 AM ET
(Mar 10)
GMTX Gemini Therapeutics 63.00 -0.41 -0.50 0.00 Gemini Therapeutics GAAP EPS of -$1.78 beats by $0.17
[3/10/2022 7:32 AM]
1.48 -0.07 
1.55 0.0 
0.0 - 0.0 47,670 0 0
15-11-2021 PM GMTX Gemini Therapeutics 147.00 -0.43 -0.47 0.00 Gemini Therapeutics EPS beats by $0.04
[11/15/2021 7:59 AM]
3.58 0.16 
3.50 0.08 
3.22 - 19.09 213,596 120,000 1,534